Emerging Research

Will Hodgkin Lymphoma Patients Benefit From Checkpoint Inhibitors?

Do checkpoint inhibitors have a role in Hodgkin lymphoma care as a frontline treatment? Watach as Dr. Andrew Evens and Dr. Joshua Brody discuss the latest research developments, immunotherapy and more.

Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr

Emerging Research

Treatment Developments and Ongoing Hodgkin Lymphoma Research

Expert Dr. John Burke discusses what’s new in the world of Hodgkin lymphoma. Watch now to learn about new studies on the use of radiation, how to treat early stage patients, and more.